Closing the diagnostic gap in endometrial cancer.
Endometrial cancer is the most common gynecologic cancer in the United States and the only major one with no screening test. The Foundation works on the part of the pathway that comes before a diagnosis, where almost nobody else is.
A gap hiding in plain sight.
In other areas of women's health, routine screening has become embedded in ordinary practice. A woman expects a mammogram. She expects a Pap. The expectation itself does a great deal of the work.
Endometrial cancer has no equivalent. Detection is reactive, dependent on a symptom appearing rather than on anything scheduled. The result is variability in what women are told, inconsistency in how they are evaluated, and unequal outcomes. Some women are caught early. Many are not. Too often the difference comes down to luck.
Patient need defines the mission across the whole pathway
A woman with symptoms needs a fast, competent route to a diagnosis. A woman with a known risk needs a plan built around it. A woman who feels well, with no reason yet to think about any of this, deserves the truth: symptoms are not screening, and no screening test for this disease exists yet.
Waiting for a warning sign is not early detection. It is reaction.
Three things have to change at once.
What women know to ask for, what clinicians know to offer, and what families understand is at stake. Change one without the others and nothing moves.
What women know to ask for
We help women understand their own risk, recognize what counts as abnormal, and walk into an exam room with the specific question already formed. A specific question gets a different appointment.
What clinicians know to offer
We support the shift toward proactive, risk-aware, office-based evaluation, so the system meets women earlier rather than later. The Foundation does not provide clinical care or direct clinical decisions.
What families understand is at stake
A diagnosis arrives in a woman's body and then moves through a household. We bring husbands, fathers, sons and brothers into the work, because the person who says it has gone on too long is often not the patient.
And where the gap is widest
Black women die of this disease at nearly twice the rate of white women, and the ultrasound used to triage bleeding performs measurably worse where fibroids are more common. Reaching those women earlier is built into the work, not added to it.
Five program areas, one system.
Not a set of separate initiatives. Five areas that reinforce each other, so that education leads to a question, a question leads to an evaluation, and what we learn goes back into the education.
Education and Awareness
Plain-language explainers, symptom checklists, downloadable guides and newsletter education, distributed through digital channels and community partners. All materials are general in nature and do not constitute medical advice. See the free guides.
Patient Expectation and Engagement
Tools that help a woman become an informed participant in her own care: what-to-ask scripts, appointment preparation, family conversation frameworks. They reduce uncertainty and improve the conversation without directing clinical decisions. The questions to ask.
Clinical Pathway and Systems Awareness
Convenings, clinician roundtables, general frameworks, and where the opportunity is right, funding independent research designed and overseen by clinical and public health partners. The Foundation does not provide clinical care.
Access and Equity
Partnerships, translated materials and targeted outreach so the work reaches women facing the greatest barriers to information and care, including through safety-net clinics and community distribution.
Program Evaluation and Continuous Improvement
We track what we can honestly count: guide downloads, newsletter sign-ups, partner organizations distributing materials, event attendance and survey feedback. These are engagement measures. We do not provide care and we do not track patient outcomes.
An endorsing organization of the National Strategy to Close the Women's Health Gap.
In August 2026 the Foundation joined more than fifty organizations endorsing the National Strategy to Close the Women's Health Gap, a $20 billion, ten-year federal framework launched in July 2026 by the Society for Women's Health Research, the American College of Obstetricians and Gynecologists, and the Women First Research Coalition.
Our name sits alongside the Society of Gynecologic Oncology, Susan G. Komen, the American Heart Association, the American Diabetes Association and the Endocrine Society.
We are there for the women and families who have not been diagnosed yet. Before the symptoms, before the referral, before anyone is a patient.
Said plainly, because you should not have to go looking.
The Eva Tucci Foundation for Early Detection & Prevention is an independent nonprofit, charitable and educational organization recognized by the IRS as tax-exempt under Section 501(c)(3), EIN 41-5225790.
The Foundation was incubated with early operational support from Utepreva, a women's health company. It is separately incorporated, governed by its own board, and raises its own funds. It promotes no product, and nothing on this site recommends or endorses any specific product, technology or commercial entity.
Its materials are general in nature and do not constitute medical advice. It does not provide clinical care.